NCT03991611

Brief Summary

Reducing discomfort in the intensive care unit (ICU) should be beneficial to longterm outcomes. This study assesses whether a tailored multicomponent program for discomfort reduction may be effective in reducing post-traumatic stress disorder (PTSD) symptoms at 1-year in general ICU survivors. The psychiatric morbidity may be increased by the COVID-19 epidemic and its consequences on the healthcare system (patient care, reorganization of French ICUs). The main objective of PTSD-REA\_COVID cohort is to assess this psychiatric morbidity 6 months after an ICU stay during the epidemic period.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,312

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2019

Typical duration for not_applicable

Geographic Reach
1 country

33 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 19, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

November 1, 2019

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
Last Updated

March 23, 2022

Status Verified

July 1, 2021

Enrollment Period

2.7 years

First QC Date

June 11, 2019

Last Update Submit

March 8, 2022

Conditions

Keywords

Critical carePost-traumatic stress disorderDiscomfortTailored programPatient-reported outcomeICUCOVID-19

Outcome Measures

Primary Outcomes (1)

  • Presence of posttraumatic stress disorder (PTSD) symptoms at one year after ICU discharge and 6 months ( PTSD-REA_COVID cohort)

    PTSD symptoms at one year will be assessed from the PCL-5 which is a 20-item self-report measure that assesses the 20 DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) symptoms of PTSD. Each item is rated from 0 "Not at all" to 4 "Extremely". A total symptom severity score (range - 0-80) can be obtained by summing the scores for each of the 20 items. A provisional PTSD diagnosis can be made by treating each item rated as 2 = "Moderately" or higher as a symptom endorsed, then following the DSM-5 diagnostic rule which requires at least: 1 B item (questions 1-5), 1 C item (questions 6-7), 2 D items (questions 8-14), 2 E items (questions 15-20).

    One year after ICU discharge

Secondary Outcomes (16)

  • ICU stay's duration

    The day of ICU discharge

  • Number of days with mechanical ventilation

    The day of ICU discharge

  • Overall score of discomfort assessed from the IPREA3 questionnaire

    The day of ICU discharge

  • The duration of hospital stay after ICU discharge

    6 months ( PTSD-REA_COVID cohort) or 1 year after ICU discharge and

  • Intrusion Symptom Category B assessed from the PCL-5 (Posttraumatic Stress Disorder Checklist ) (Items 1-5)

    6 months ( PTSD-REA_COVID cohort) and1 year after ICU discharge

  • +11 more secondary outcomes

Study Arms (4)

IPREA3 program

EXPERIMENTAL

Application of the IPREA 3 program (multicomponent intervention to reduce perceived discomforts in critically ill patients) for at least 5 months

Other: Administration of the IPREA3 questionnaireOther: Immediate feedback through electronic reminder messagesOther: Targeted interventions in each ICU to reduce discomfortsOther: 1 year follow-up to assess psychiatric morbidity

Intermediate group

OTHER

Application of the IPREA 3 program (multicomponent intervention to reduce perceived discomforts in critically ill patients) for less than 5 months

Other: Administration of the IPREA3 questionnaireOther: Immediate feedback through electronic reminder messagesOther: Targeted interventions in each ICU to reduce discomforts

Standard care

ACTIVE COMPARATOR

Standard care

Other: Administration of the IPREA3 questionnaireOther: 1 year follow-up to assess psychiatric morbidity

PTSD-REA_COVID cohort

OTHER

ICU admission between March 1, 2020 and April 30, 2020.

Other: 6 months follow-up to assess the prevalence of PTSD symptomsOther: 1 year follow-up to assess psychiatric morbidity

Interventions

On the day of the ICU discharge, the bedside nurse administers to the patient the 18-item IPREA questionnaire i.e the nurse asks the patient to rate from 0 to 10 the severity of each discomfort source contained in the IPREA3 questionnaire experienced during the entire stay in the ICU

IPREA3 programIntermediate groupStandard care

After the nurse had administered the questionnaire, warning messages are displayed on the screen corresponding to the key points to prevent the three discomforts reported with the highest scores

IPREA3 programIntermediate group

These targeted interventions are implemented through the coordination of two local champions. The central coordination IPREA3 team sends each month to the local champions monthly and cumulative discomfort scores of their unit (overall score of discomfort and scores for each item) and their ranking relative to other units assigned to the interventional arm i.e applying the IPREA3 program. The local champions organize monthly meetings with the unit staff to present the results in terms of perceived discomforts measured by the IPREA questionnaire, identify main discomfort sources and actions to be conducted to reduce the discomforts reported with the highest scores in the unit and those that are most easily preventable, and assess the efficacy of already applied measures.

IPREA3 programIntermediate group

Psychologist will collect the PCL-5, HAD-S, WHOQOL-BREF, LEC-5 items during the telephone follow-up, 6 months after ICU discharge .

PTSD-REA_COVID cohort

Psychologist will collect the PCL-5, HAD-S, WHOQOL-BREF, LEC-5 and CTQ items during the telephone follow-up, 1 year after ICU discharge .

IPREA3 programPTSD-REA_COVID cohortStandard care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who survived an ICU stay of at least 3 calendar days
  • Affiliation to a social security scheme
  • First stay in ICU during current short-term hospitalization
  • Patient's oral consent to participate in the PTSD-REA\_COVID cohort

You may not qualify if:

  • Deceased during the ICU stay
  • Minors
  • Under trusteeship
  • Without affiliation to a social security scheme
  • Transferred to another ICU
  • Already hospitalized in ICU during the current short stay
  • Already included in the study
  • Limitation and cessation of active treatment
  • Advance healthcare directive indicating the refusal of ICU stay
  • Irreversible state like diminished cognitive capacity based on the investigator's opinion or not understanding French sufficiently to be questioned (language barrier)
  • Subject not consenting to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (33)

CHU Angers

Angers, 49100, France

Location

CHU d'Angers

Angers, 49933, France

Location

CH d'Auxerre

Auxerre, 89000, France

Location

CH de Blois

Blois, 41016, France

Location

Clinique Convert

Bourg-en-Bresse, 01000, France

Location

CH Bourges

Bourges, 18033, France

Location

HĂ´pital Louis Pasteur

Chartres, 28000, France

Location

CHU de Dijon

Dijon, 21079, France

Location

CH de Douai

Douai, 59507, France

Location

CH Emile Roux

Le Puy-en-Velay, 43000, France

Location

CH de Lens

Lens, 62300, France

Location

HĂ´pital Edouard Herriot

Lyon, 69437, France

Location

Hôpital Européen de Marseille

Marseille, 13003, France

Location

HĂ´pital Nord_APHM

Marseille, 13015, France

Location

HĂ´pital Nord_APHM

Marseille, 13326, France

Location

CH de MĂ¢con

MĂ¢con, 71000, France

Location

CH de l'Agglomération Montargoise

Montargis, 45207, France

Location

GHR Mulhouse Sud-Alsace

Mulhouse, 68100, France

Location

Clinique Ambroise Paré

Neuilly-sur-Seine, 92200, France

Location

HĂ´pital Pasteur 2_CHU de Nice

Nice, 06006, France

Location

HĂ´pital Saint-Louis_APHP

Paris, 75010, France

Location

Gaston Cordier_GH La PitiĂ©-SalpĂªtrière-Charles Foix_APHP

Paris, 75013, France

Location

GH La PitiĂ©-SalpĂªtrière-Charles Foix_APHP

Paris, 75013, France

Location

Husson Mourier_GH La PitiĂ©-SalpĂªtrière-Charles Foix_APHP

Paris, 75013, France

Location

CHU de Poitiers

Poitiers, 86021, France

Location

Hôpital privé Claude Galien

Quincy-sous-Sénart, 91480, France

Location

CH Victor Provo

Roubaix, 59100, France

Location

NCT+ - St Gatien

Saint-Cyr-sur-Loire, 37540, France

Location

Nouvel HĂ´pital Civil_CHU de Strasbourg

Strasbourg, 67091, France

Location

HĂ´pital de Hautepierre_CHU de Strasbourg

Strasbourg, 67098, France

Location

HĂ´pital Sainte Musse

Toulon, 83000, France

Location

CHRU de Tours

Tours, 37044, France

Location

CH de Troyes

Troyes, 1000, France

Location

Related Publications (37)

  • Jones C. Surviving the intensive care: residual physical, cognitive, and emotional dysfunction. Thorac Surg Clin. 2012 Nov;22(4):509-16. doi: 10.1016/j.thorsurg.2012.07.003. Epub 2012 Aug 25.

  • Jones C, Skirrow P, Griffiths RD, Humphris GH, Ingleby S, Eddleston J, Waldmann C, Gager M. Rehabilitation after critical illness: a randomized, controlled trial. Crit Care Med. 2003 Oct;31(10):2456-61. doi: 10.1097/01.CCM.0000089938.56725.33.

  • Pacella ML, Hruska B, Delahanty DL. The physical health consequences of PTSD and PTSD symptoms: a meta-analytic review. J Anxiety Disord. 2013 Jan;27(1):33-46. doi: 10.1016/j.janxdis.2012.08.004. Epub 2012 Sep 13.

  • Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, Brummel NE, Hughes CG, Vasilevskis EE, Shintani AK, Moons KG, Geevarghese SK, Canonico A, Hopkins RO, Bernard GR, Dittus RS, Ely EW; BRAIN-ICU Study Investigators. Long-term cognitive impairment after critical illness. N Engl J Med. 2013 Oct 3;369(14):1306-16. doi: 10.1056/NEJMoa1301372.

  • Davydow DS, Hough CL, Zatzick D, Katon WJ. Psychiatric symptoms and acute care service utilization over the course of the year following medical-surgical ICU admission: a longitudinal investigation*. Crit Care Med. 2014 Dec;42(12):2473-81. doi: 10.1097/CCM.0000000000000527.

  • Dowdy DW, Eid MP, Dennison CR, Mendez-Tellez PA, Herridge MS, Guallar E, Pronovost PJ, Needham DM. Quality of life after acute respiratory distress syndrome: a meta-analysis. Intensive Care Med. 2006 Aug;32(8):1115-24. doi: 10.1007/s00134-006-0217-3. Epub 2006 Jun 17.

  • Granja C, Lopes A, Moreira S, Dias C, Costa-Pereira A, Carneiro A; JMIP Study Group. Patients' recollections of experiences in the intensive care unit may affect their quality of life. Crit Care. 2005 Apr;9(2):R96-109. doi: 10.1186/cc3026. Epub 2005 Jan 31.

  • McKinley S, Aitken LM, Alison JA, King M, Leslie G, Burmeister E, Elliott D. Sleep and other factors associated with mental health and psychological distress after intensive care for critical illness. Intensive Care Med. 2012 Apr;38(4):627-33. doi: 10.1007/s00134-012-2477-4. Epub 2012 Feb 9.

  • Schelling G, Richter M, Roozendaal B, Rothenhausler HB, Krauseneck T, Stoll C, Nollert G, Schmidt M, Kapfhammer HP. Exposure to high stress in the intensive care unit may have negative effects on health-related quality-of-life outcomes after cardiac surgery. Crit Care Med. 2003 Jul;31(7):1971-80. doi: 10.1097/01.CCM.0000069512.10544.40.

  • Bienvenu OJ, Gellar J, Althouse BM, Colantuoni E, Sricharoenchai T, Mendez-Tellez PA, Shanholtz C, Dennison CR, Pronovost PJ, Needham DM. Post-traumatic stress disorder symptoms after acute lung injury: a 2-year prospective longitudinal study. Psychol Med. 2013 Dec;43(12):2657-71. doi: 10.1017/S0033291713000214. Epub 2013 Feb 26.

  • Davydow DS, Gifford JM, Desai SV, Needham DM, Bienvenu OJ. Posttraumatic stress disorder in general intensive care unit survivors: a systematic review. Gen Hosp Psychiatry. 2008 Sep-Oct;30(5):421-34. doi: 10.1016/j.genhosppsych.2008.05.006. Epub 2008 Jul 30.

  • Jones C, Griffiths RD, Humphris G, Skirrow PM. Memory, delusions, and the development of acute posttraumatic stress disorder-related symptoms after intensive care. Crit Care Med. 2001 Mar;29(3):573-80. doi: 10.1097/00003246-200103000-00019.

  • Schelling G, Stoll C, Haller M, Briegel J, Manert W, Hummel T, Lenhart A, Heyduck M, Polasek J, Meier M, Preuss U, Bullinger M, Schuffel W, Peter K. Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome. Crit Care Med. 1998 Apr;26(4):651-9. doi: 10.1097/00003246-199804000-00011.

  • Jackson JC, Hart RP, Gordon SM, Hopkins RO, Girard TD, Ely EW. Post-traumatic stress disorder and post-traumatic stress symptoms following critical illness in medical intensive care unit patients: assessing the magnitude of the problem. Crit Care. 2007;11(1):R27. doi: 10.1186/cc5707.

  • Parker AM, Sricharoenchai T, Raparla S, Schneck KW, Bienvenu OJ, Needham DM. Posttraumatic stress disorder in critical illness survivors: a metaanalysis. Crit Care Med. 2015 May;43(5):1121-9. doi: 10.1097/CCM.0000000000000882.

  • Patel MB, Jackson JC, Morandi A, Girard TD, Hughes CG, Thompson JL, Kiehl AL, Elstad MR, Wasserstein ML, Goodman RB, Beckham JC, Chandrasekhar R, Dittus RS, Ely EW, Pandharipande PP. Incidence and Risk Factors for Intensive Care Unit-related Post-traumatic Stress Disorder in Veterans and Civilians. Am J Respir Crit Care Med. 2016 Jun 15;193(12):1373-81. doi: 10.1164/rccm.201506-1158OC.

  • Garrouste-Orgeas M, Coquet I, Perier A, Timsit JF, Pochard F, Lancrin F, Philippart F, Vesin A, Bruel C, Blel Y, Angeli S, Cousin N, Carlet J, Misset B. Impact of an intensive care unit diary on psychological distress in patients and relatives*. Crit Care Med. 2012 Jul;40(7):2033-40. doi: 10.1097/CCM.0b013e31824e1b43.

  • Cuthbertson BH, Rattray J, Campbell MK, Gager M, Roughton S, Smith A, Hull A, Breeman S, Norrie J, Jenkinson D, Hernandez R, Johnston M, Wilson E, Waldmann C; PRaCTICaL study group. The PRaCTICaL study of nurse led, intensive care follow-up programmes for improving long term outcomes from critical illness: a pragmatic randomised controlled trial. BMJ. 2009 Oct 16;339:b3723. doi: 10.1136/bmj.b3723.

  • Bergbom-Engberg I, Haljamae H. Patient experiences during respirator treatment--reason for intermittent positive-pressure ventilation treatment and patient awareness in the intensive care unit. Crit Care Med. 1989 Jan;17(1):22-5. doi: 10.1097/00003246-198901000-00006.

  • Nelson JE, Meier DE, Oei EJ, Nierman DM, Senzel RS, Manfredi PL, Davis SM, Morrison RS. Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med. 2001 Feb;29(2):277-82. doi: 10.1097/00003246-200102000-00010.

  • Novaes MA, Knobel E, Bork AM, Pavao OF, Nogueira-Martins LA, Ferraz MB. Stressors in ICU: perception of the patient, relatives and health care team. Intensive Care Med. 1999 Dec;25(12):1421-6. doi: 10.1007/s001340051091.

  • Rotondi AJ, Chelluri L, Sirio C, Mendelsohn A, Schulz R, Belle S, Im K, Donahoe M, Pinsky MR. Patients' recollections of stressful experiences while receiving prolonged mechanical ventilation in an intensive care unit. Crit Care Med. 2002 Apr;30(4):746-52. doi: 10.1097/00003246-200204000-00004.

  • Simini B. Patients' perceptions of intensive care. Lancet. 1999 Aug 14;354(9178):571-2. doi: 10.1016/S0140-6736(99)02728-2.

  • Soehren P. Stressors perceived by cardiac surgical patients in the intensive care unit. Am J Crit Care. 1995 Jan;4(1):71-6.

  • Kalfon P, Mimoz O, Auquier P, Loundou A, Gauzit R, Lepape A, Laurens J, Garrigues B, Pottecher T, Malledant Y. Development and validation of a questionnaire for quantitative assessment of perceived discomforts in critically ill patients. Intensive Care Med. 2010 Oct;36(10):1751-1758. doi: 10.1007/s00134-010-1902-9. Epub 2010 May 26.

  • Kalfon P, Baumstarck K, Estagnasie P, Geantot MA, Berric A, Simon G, Floccard B, Signouret T, Boucekine M, Fromentin M, Nyunga M, Sossou A, Venot M, Robert R, Follin A, Audibert J, Renault A, Garrouste-Orgeas M, Collange O, Levrat Q, Villard I, Thevenin D, Pottecher J, Patrigeon RG, Revel N, Vigne C, Azoulay E, Mimoz O, Auquier P; IPREA Study group. A tailored multicomponent program to reduce discomfort in critically ill patients: a cluster-randomized controlled trial. Intensive Care Med. 2017 Dec;43(12):1829-1840. doi: 10.1007/s00134-017-4991-x. Epub 2017 Nov 27.

  • Kalfon P, Alessandrini M, Boucekine M, Renoult S, Geantot MA, Deparis-Dusautois S, Berric A, Collange O, Floccard B, Mimoz O, Julien A, Robert R, Audibert J, Renault A, Follin A, Thevenin D, Revel N, Venot M, Patrigeon RG, Signouret T, Fromentin M, Sharshar T, Vigne C, Pottecher J, Levrat Q, Sossou A, Garrouste-Orgeas M, Quenot JP, Boulle C, Azoulay E, Baumstarck K, Auquier P; IPREA-AQVAR Study Group. Tailored multicomponent program for discomfort reduction in critically ill patients may decrease post-traumatic stress disorder in general ICU survivors at 1 year. Intensive Care Med. 2019 Feb;45(2):223-235. doi: 10.1007/s00134-018-05511-y. Epub 2019 Jan 30.

  • Creamer M, Bell R, Failla S. Psychometric properties of the Impact of Event Scale - Revised. Behav Res Ther. 2003 Dec;41(12):1489-96. doi: 10.1016/j.brat.2003.07.010.

  • Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL. The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and Initial Psychometric Evaluation. J Trauma Stress. 2015 Dec;28(6):489-98. doi: 10.1002/jts.22059. Epub 2015 Nov 25.

  • Birmes P, Brunet A, Benoit M, Defer S, Hatton L, Sztulman H, Schmitt L. Validation of the Peritraumatic Dissociative Experiences Questionnaire self-report version in two samples of French-speaking individuals exposed to trauma. Eur Psychiatry. 2005 Mar;20(2):145-51. doi: 10.1016/j.eurpsy.2004.06.033.

  • Jehel L, Brunet A, Paterniti S, Guelfi JD. [Validation of the Peritraumatic Distress Inventory's French translation]. Can J Psychiatry. 2005 Jan;50(1):67-71. doi: 10.1177/070674370505000112. French.

  • Gray MJ, Litz BT, Hsu JL, Lombardo TW. Psychometric properties of the life events checklist. Assessment. 2004 Dec;11(4):330-41. doi: 10.1177/1073191104269954.

  • Kubany ES, Haynes SN, Leisen MB, Owens JA, Kaplan AS, Watson SB, Burns K. Development and preliminary validation of a brief broad-spectrum measure of trauma exposure: the Traumatic Life Events Questionnaire. Psychol Assess. 2000 Jun;12(2):210-24. doi: 10.1037//1040-3590.12.2.210.

  • Bernstein DP, Fink L, Handelsman L, Foote J, Lovejoy M, Wenzel K, Sapareto E, Ruggiero J. Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am J Psychiatry. 1994 Aug;151(8):1132-6. doi: 10.1176/ajp.151.8.1132.

  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.

  • Baumann C, Erpelding ML, Regat S, Collin JF, Briancon S. The WHOQOL-BREF questionnaire: French adult population norms for the physical health, psychological health and social relationship dimensions. Rev Epidemiol Sante Publique. 2010 Feb;58(1):33-9. doi: 10.1016/j.respe.2009.10.009. Epub 2010 Jan 21.

  • Kalfon P, El-Hage W, Geantot MA, Favier C, Bodet-Contentin L, Kuteifan K, Olivier PY, Thevenin D, Pottecher J, Crozon-Clauzel J, Mauchien B, Galbois A, de Varax R, Valera S, Estagnasie P, Berric A, Nyunga M, Revel N, Simon G, Kowalski B, Sossou A, Signouret T, Leone M, Delale C, Seemann A, Lasocki S, Quenot JP, Monsel A, Michel O, Page M, Patrigeon RG, Nicola W, Thille AW, Hekimian G, Auquier P, Baumstarck K; PTSD-REA Study group. Impact of COVID-19 on posttraumatic stress disorder in ICU survivors: a prospective observational comparative cohort study. Crit Care. 2024 Mar 14;28(1):77. doi: 10.1186/s13054-024-04826-1.

MeSH Terms

Conditions

Critical IllnessStress Disorders, Post-TraumaticCOVID-19

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsStress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Pierre KALFON, MD PhD

    CH Chartres

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
SEQUENTIAL
Model Details: Stepped wedge cluster randomized trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2019

First Posted

June 19, 2019

Study Start

November 1, 2019

Primary Completion

July 31, 2022

Study Completion

January 1, 2023

Last Updated

March 23, 2022

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will share

Locations